Alginic Acid
No structure available
Alginic Acid could not be matched to a single known compound.
Background
Listing
- Schedules
- Schedule 4, conditions apply
- Exceptions reach
- Schedule 0
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
Counted through the register's ingredient index, which does not reach every record.
3 more registered products name Alginic Acid in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Alginic acid, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate Cancelled | Gelacid, Gastrocote | tablets | 2 applicants | 2 registrations | |
| Alginic acid, aluminium hydroxide, magnesium trisilicate, sodium alginate, sodium bicarbonate | Gaviscon | Not stated | Reckitt Benckinser Pharmaceuticals (Pty) Ltd | C0037 | |
| Alginic acid, aluminiumhydroxide, mag carbonate codried, sodium bicarbonate Cancelled | Telament mints | Not stated | Adcock ingram limited | Y0252 |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Alginic acid
S4: Alginic Acid
- its salts and complexes thereof, when intended for use in gastric regurgitation, gastro-oesophageal reflux and reflux associated with hiatus hernia in infants and young children under the age of 6 years. (S0)
Consolidated Schedules 06 July 2026, lines 5156 to 5157
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.